Participants 56 92 5
AJCC/UICC stage II colorectal cancer
Participants 357 473 4
patients with American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) stage II disease
Participants 483 783 9
Tumors of 120 randomly selected patients with AJCC/UICC stage II disease were retrospectively reviewed for tumor growth pattern (expanding vs. infiltrating) and the extent of tumor budding, with high-grade budding reflecting presence of 10 or more budding foci scattered at the invasive tumor margin.
Participants 1806 1859 4
tcome in patients with AJCC/UICC stage II colorectal 
